Importantly, we validated these biomarkers using qRT-PCR and found that the gene expression rate of protective factors such as AC093159.1/ TYMSOS, SCAT1 /LINC00460 and Z82243.1/LINC02561 was significantly higher in early versus late tumor stages. This evidence concerns the gene SCAT1 and neoplasm.